Scientists analyzed clinical data and differentially expressed miRNAs in CD34+ chronic myeloid leukemia cells from 80 patients at diagnosis who were later classified as imatinib-responders or imatinib-nonresponders.
[Leukemia]
Identification of Multivariable microRNA and Clinical Biomarker Panels to Predict Imatinib Response in Chronic Myeloid Leukemia at Diagnosis
